產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-Apolipoprotein E4抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Apolipoprotein E4抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Apolipoprotein E4
Cat. Number:
Anti-Apolipoprotein E4抗體XY-5038R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. Anti-Apolipoprotein E4抗體Compared with E3 and E4, E2 exhibits the lowest receptor binding affinity. Defects in ApoE are a cause of hyperlipoproteinemia type III due to increased plasma cholesterol and triglycerides levels which are the consequence of impaired clearance of chylomicron and VLDL remnants.
Summary: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jul 2008].
Summary: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jul 2008].
Also known as:
APOE4; Apolipoprotein Anti-Apolipoprotein E4抗體E4; AD2; Alzheimer disease 2 (APOE*E4 associated, late onset); Apo E4; APOE; apoe4; Apolipoprotein E; Apolipoprotein E3; LDLCQ5; LPG; MGC1571.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human APOE4.
●
Predicted Molecular Anti-Apolipoprotein E4抗體Weight: 34kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
Anti-Apolipoprotein E4抗體WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
xy-5715R GIG34細(xì)胞生長(zhǎng)抑制蛋白34
xy-6579R Growth Hormone生長(zhǎng)**抗體
xy-13460R GMPPAGDP甘露糖焦磷酸化酶抗體
xy-6564R GPR171G蛋白偶聯(lián)受體171抗體
xy-11847R GPM6B神經(jīng)細(xì)胞膜糖蛋白M6b
xy-6247R GUK1鳥苷酸激酶GMK抗體
xy-4691R Galactocerebroside半乳糖腦苷脂酶抗體
xy-7540R GRK5G蛋白偶聯(lián)受體激酶5抗體
xy-7502R GTP binding protein REM1GTP結(jié)合蛋白R(shí)EM1抗體
xy-4692R phospho-GSK3 Alpha(Ser21)磷酸化糖原合酶激酶-3α抗體
xy-11461R GDF7生長(zhǎng)分化因子7抗體
xy-7057R Glucokinase regulatory protein葡萄糖激酶調(diào)節(jié)蛋白抗體
xy-8402R GCLCγ谷氨酰半胱氨酸合成酶抗體（γ-GCSc）
xy-8403R GCOM1GCOM1蛋白抗體
xy-8405R GFOD2葡萄糖果糖還原酶2抗體
xy-8406R GFRAL膠質(zhì)細(xì)胞系源性神經(jīng)營(yíng)養(yǎng)因子受體α1樣蛋白抗體
xy-8407R GHDCGHDC蛋白抗體
xy-8408R GK5甘油激酶5抗體
xy-8409R GLB1L3β半乳糖苷酶1樣蛋白3抗體
xy-8410R GLCCI1糖皮質(zhì)**誘導(dǎo)轉(zhuǎn)錄蛋白1抗體
xy-8411R GLIPR2腦膠質(zhì)瘤發(fā)病相關(guān)蛋白2抗體
xy-11725R GDAP1神經(jīng)節(jié)苷脂誘導(dǎo)分化相關(guān)蛋白1抗體
xy-12015R GPR18G蛋白偶聯(lián)受體18抗體
xy-12016R GPR119G蛋白偶聯(lián)受體119抗體
xy-12017R GPR88G蛋白偶聯(lián)受體88抗體
xy-12021R GPR125G蛋白偶聯(lián)受體125抗體
